Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Acta Diabetologica|June 21, 2022
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathyFrancesca D'Addio, Ida Pastore, Cristian Loretelli, et al.
Pharmacological Research|December 21, 2023
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutideMaria Elena Lunati, Vincenzo Cimino, Davide Bernasconi, et al.
JCI Insight|November 16, 2021
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune responseCristian Loretelli, Ahmed Abdelsalam, Francesca D'Addio, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2024
Vaccinome Landscape in Nearly 620 000 Patients With DiabetesFrancesca D'Addio, Elisa Lazzaroni, Maria Elena Lunati, et al.
Diabetes|May 13, 2022
Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 DiabetesFrancesca D'Addio, Gianmarco Sabiu, Vera Usuelli, et al.
Pharmacological Research|July 31, 2022
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE studyElisa Lazzaroni, Maria Elena Lunati, Laura Montefusco, et al.
Nature Metabolism|May 26, 2021
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infectionLaura Montefusco, Moufida Ben Nasr, Francesca D'Addio, et al.
The Journal of Clinical Investigation|May 15, 2025
TMEM219 signaling promotes intestinal stem cell death and exacerbates colitisFrancesca D'Addio, Giovanni Amabile, Emma Assi, et al.
Pharmacological Research|December 31, 2025
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and Type 2 Diabetes via 5-HT2B receptor-dependent mechanismsMartina Colognesi, Daniela Gabbia, Anna Signor, et al.
Diabetes|May 2, 2022
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic IsletsMoufida Ben Nasr, Francesca D'Addio, Laura Montefusco, et al.
Pageof 5